Published in Circulation on March 08, 2010
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol (2015) 2.95
Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study. Am J Kidney Dis (2011) 1.83
Creatinine generation is reduced in patients requiring continuous venovenous hemodialysis and independently predicts mortality. Nephrol Dial Transplant (2012) 1.71
Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study. Kidney Int (2016) 1.52
Established and emerging markers of kidney function. Clin Chem (2012) 1.45
Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol (2011) 1.43
Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle (2012) 1.42
Association of body mass index with outcomes in patients with CKD. J Am Soc Nephrol (2014) 1.30
Influence of urine creatinine on the relationship between the albumin-to-creatinine ratio and cardiovascular events. Clin J Am Soc Nephrol (2012) 1.00
Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Clin J Am Soc Nephrol (2014) 1.00
Urine creatinine excretion and clinical outcomes in CKD. Clin J Am Soc Nephrol (2013) 0.89
Sex, Myocardial Infarction, and the Failure of Risk Scores in Women. J Womens Health (Larchmt) (2015) 0.87
Decrease in urinary creatinine excretion in early stage chronic kidney disease. PLoS One (2014) 0.87
24-hour urine phosphorus excretion and mortality and cardiovascular events. Clin J Am Soc Nephrol (2013) 0.86
The extinguished BEACON of bardoxolone: not a Monday morning quarterback story. Am J Nephrol (2013) 0.85
Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis. Am J Kidney Dis (2013) 0.84
Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study. J Am Soc Nephrol (2015) 0.83
Association between kidney function and telomere length: the heart and soul study. Am J Nephrol (2012) 0.83
Estimating glomerular filtration rate in older people. Biomed Res Int (2014) 0.83
Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients. J Thorac Dis (2016) 0.82
Urine calcium excretion, cardiovascular events, and mortality in outpatients with stable coronary artery disease (from the Heart and Soul study). Am J Cardiol (2012) 0.80
Null association between abdominal muscle and calcified atherosclerosis in community-living persons without clinical cardiovascular disease: the multi-ethnic study of atherosclerosis. Metabolism (2013) 0.79
Chronic kidney disease: High eGFR and mortality: high true GFR or a marker of frailty? Nat Rev Nephrol (2011) 0.79
A good reason to measure 24-hour urine creatinine excretion, but not to assess kidney function. Clin J Am Soc Nephrol (2013) 0.79
Creatinine excretion rate, a marker of muscle mass, is related to clinical outcome in patients with chronic systolic heart failure. Clin Res Cardiol (2014) 0.78
Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy. Clin J Am Soc Nephrol (2016) 0.77
Enhanced exercise-induced muscle damage and muscle protein degradation in streptozotocin-induced type 2 diabetic rats. J Diabetes Investig (2011) 0.77
Relation of body mass index to urinary creatinine excretion rate in patients with coronary heart disease. Am J Cardiol (2011) 0.77
Association of Obesity and Kidney Function Decline among Non-Diabetic Adults with eGFR > 60 ml/min/1.73m(2): Results from the Multi-Ethnic Study of Atherosclerosis (MESA). Open J Endocr Metab Dis (2013) 0.77
Urine creatinine-based estimates of fat-free mass in community-dwelling older persons: the Rancho Bernardo study. J Ren Nutr (2014) 0.76
A modest proposal for improving the accuracy of creatinine-based GFR-estimating equations. Nephrol Dial Transplant (2011) 0.76
Serum cystatin C as a biomarker for predicting coronary artery disease in diabetes. Korean Diabetes J (2010) 0.76
Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2013) 0.76
Relationship of urine dopamine with phosphorus homeostasis in humans: the heart and soul study. Am J Nephrol (2012) 0.76
Brief Report: Cumulative Tenofovir Disoproxil Fumarate Exposure is Associated With Biomarkers of Tubular Injury and Fibrosis in HIV-Infected Men. J Acquir Immune Defic Syndr (2016) 0.76
Associations of body composition measures and C2, a marker for small artery elasticity: The MESA. Obesity (Silver Spring) (2015) 0.75
Relationship Between Sarcopenia and Albuminuria: The 2011 Korea National Health and Nutrition Examination Survey. Medicine (Baltimore) (2016) 0.75
Invited commentary: Quantifying salt in urine--a complex solution. Am J Epidemiol (2013) 0.75
Associations between the number of natural teeth and renal dysfunction. Medicine (Baltimore) (2016) 0.75
Low baseline urine creatinine excretion rate predicts poor outcomes among critically ill acute stroke patients. Curr Neurovasc Res (2015) 0.75
Urinary creatinine and survival in CKD. Clin J Am Soc Nephrol (2014) 0.75
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr (1990) 25.24
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61
Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50
Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest (1999) 4.23
Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr (1983) 2.89
Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry (2007) 2.44
Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr (1982) 2.41
For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int (2009) 2.32
Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis (2009) 1.88
Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. J Am Soc Nephrol (2003) 1.72
Clinical evaluation of kidney function--glomerular function. N Engl J Med (1971) 1.63
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. Am J Med (2008) 1.45
Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol (1994) 1.44
Urinary output of creatine and creatinine associated with physical exercise, and its relationship to carbohydrate metabolism. Biochem J (1939) 1.28
Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail (2006) 1.21
Cardiovascular disease risk factors in habitual exercisers, lean sedentary men and abdominally obese sedentary men. Int J Obes (Lond) (2005) 1.03
The variability of creatinine excretion in normal subjects, mental patients and pregnant women. Clin Chim Acta (1969) 1.01
Left ventricular mass and volume/mass ratio determined by two-dimensional echocardiography in normal adults. J Am Coll Cardiol (1985) 0.98
Relationship of body composition and cardiovascular fitness to lipoprotein lipid profiles in master athletes and sedentary men. Aging (Milano) (1997) 0.96
Creatinine excretion in renal failure. Proc Soc Exp Biol Med (1954) 0.92
Characteristics of the increased adrenocortical function observed in many obese patients. Ann N Y Acad Sci (1965) 0.91
Creatinine and nitrogen excretion in seriously ill and injured patients. Surg Gynecol Obstet (1979) 0.90
Muscle metabolism and catabolism in combat casualties; systemic response to injury in combat casualties. AMA Arch Surg (1955) 0.89
Variability of venom skin tests. Curr Opin Allergy Clin Immunol (2007) 0.84
Effects of diet and infection on creatine turnover in the rat. Am J Clin Nutr (1972) 0.84
Effect of muscular exercises on urinary excretion of creatine and creatinine. Indian J Med Res (1967) 0.80
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med (2011) 7.42
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet (2013) 7.03
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.54
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2011) 6.36
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 5.35
The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med (2010) 4.89
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
The relative safety of ephedra compared with other herbal products. Ann Intern Med (2003) 4.65
Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57
Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation (2003) 4.52
Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. J Am Coll Cardiol (2004) 4.43
Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28
Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA (2004) 4.27
Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 4.10
Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85
Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol (2006) 3.85
Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med (2005) 3.81
Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA (2008) 3.55
Rapid kidney function decline and mortality risk in older adults. Arch Intern Med (2008) 3.54
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53
Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med (2012) 3.50
Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation (2012) 3.39
The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med (2002) 3.32
Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation (2006) 3.31
Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28
Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27
A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med (2005) 3.14
Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS (2009) 3.12
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA (2012) 3.10
Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03
Genetic associations with valvular calcification and aortic stenosis. N Engl J Med (2013) 3.02
Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA (2013) 2.98
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
Fetuin-A and incident diabetes mellitus in older persons. JAMA (2008) 2.92
Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol (2011) 2.90
The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med (2004) 2.86
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol (2003) 2.83
Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults. J Gerontol A Biol Sci Med Sci (2003) 2.82
B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation (2003) 2.82
Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation (2006) 2.81
Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2005) 2.75
Physical performance in peripheral arterial disease: a slower rate of decline in patients who walk more. Ann Intern Med (2006) 2.73
Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Arch Gen Psychiatry (2005) 2.73
Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol (2003) 2.72
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation (2010) 2.71
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS (2012) 2.65
Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation (2007) 2.63
Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med (2007) 2.63
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2006) 2.61
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol (2006) 2.58
Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol (2011) 2.56
The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2009) 2.53
Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation (2006) 2.50
Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol (2008) 2.47
Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2003) 2.40
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation (2006) 2.40
Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation (2004) 2.39
Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imaging (2009) 2.38
Peripheral arterial disease: morbidity and mortality implications. Circulation (2006) 2.37
Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol (2009) 2.37
Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry (2007) 2.37
Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med (2007) 2.34
Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci (2009) 2.32
Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol (2014) 2.30
Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30
Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28
Microalbuminuria in HIV infection. AIDS (2007) 2.28
Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol (2013) 2.28
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation (2006) 2.27
Relationship of uric acid with progression of kidney disease. Am J Kidney Dis (2007) 2.26
Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol (2006) 2.26
Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol (2013) 2.26
Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Arch Intern Med (2008) 2.24